Carlsmed, Inc. Common Stock (CARL)
Healthcare
Health Information Services
12.60 $
-0.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Carlsmed, Inc. Common Stock (CARL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 57.2% of the shares are freely tradable; institutional investors hold 39.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
39.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
43.7%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
57.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
13.0%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
27Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Orbimed Advisors, LLC | 4.61 | 1,252,600 | +0.0 | 03/31/2026 |
| HHG PLC | 4.52 | 1,227,452 | +7.6 | 03/31/2026 |
| Parkman Healthcare Partners LLC | 1.92 | 521,123 | +0.0 | 03/31/2026 |
| BlackRock Inc | 1.64 | 446,892 | +4.5 | 03/31/2026 |
| Vanguard Group Inc | 1.32 | 360,082 | +58.5 | 12/31/2025 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Worldwide Healthcare Ord | 3.13 | 851,862 | +0.0 | 02/28/2026 |
| Janus Henderson US Small Cap Growth MA | 2.26 | 615,375 | +0.0 | 09/30/2025 |
| Janus Henderson Venture D | 2.16 | 588,027 | +0.0 | 03/31/2026 |
| Janus Henderson US Small Cap Growth | 2.16 | 588,027 | -1.1 | 03/31/2026 |
| Janus Henderson Small Cap Value L | 1.26 | 343,579 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.